Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP928957.RA0vqyLbIpnbnxYaksSJsZf0Hjec_l3mxf8UVQxTqWMwE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP928957.RA0vqyLbIpnbnxYaksSJsZf0Hjec_l3mxf8UVQxTqWMwE130_assertion type Assertion NP928957.RA0vqyLbIpnbnxYaksSJsZf0Hjec_l3mxf8UVQxTqWMwE130_head.
- NP928957.RA0vqyLbIpnbnxYaksSJsZf0Hjec_l3mxf8UVQxTqWMwE130_assertion description "[NRP-1 was expressed in 80% and 95% of ALL and AML respectively with levels higher in patients than controls and in ALL than AML patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP928957.RA0vqyLbIpnbnxYaksSJsZf0Hjec_l3mxf8UVQxTqWMwE130_provenance.
- NP928957.RA0vqyLbIpnbnxYaksSJsZf0Hjec_l3mxf8UVQxTqWMwE130_assertion evidence source_evidence_literature NP928957.RA0vqyLbIpnbnxYaksSJsZf0Hjec_l3mxf8UVQxTqWMwE130_provenance.
- NP928957.RA0vqyLbIpnbnxYaksSJsZf0Hjec_l3mxf8UVQxTqWMwE130_assertion SIO_000772 21978468 NP928957.RA0vqyLbIpnbnxYaksSJsZf0Hjec_l3mxf8UVQxTqWMwE130_provenance.
- NP928957.RA0vqyLbIpnbnxYaksSJsZf0Hjec_l3mxf8UVQxTqWMwE130_assertion wasDerivedFrom befree-2016 NP928957.RA0vqyLbIpnbnxYaksSJsZf0Hjec_l3mxf8UVQxTqWMwE130_provenance.
- NP928957.RA0vqyLbIpnbnxYaksSJsZf0Hjec_l3mxf8UVQxTqWMwE130_assertion wasGeneratedBy ECO_0000203 NP928957.RA0vqyLbIpnbnxYaksSJsZf0Hjec_l3mxf8UVQxTqWMwE130_provenance.